Part D/Prescription Drugs – Page 15 – medicarereport.org

Friday, September 11, 2026

Latest:

FDA Part D/Prescription Drugs

Eileen Cook August 13, 2025 Contaminated drug shipments, FDA, Sun Pharma

FDA tolerated contaminated drug shipments for almost a decade: ProPublica

(By: Alexandra Murphy for Becker’s Hospital Review ) Drugmaker Sun Pharma pledged sweeping reforms after years of persistent safety violations

DHS -OIG Health Care Finance Medicare - General Part D/Prescription Drugs

Eileen Cook August 6, 2025 DHS-OIG, Drug Payments, medicare, Medicare Part B, Medicare Part B drugs

Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2023 Average Sales Prices

(Source - oig.hhs.gov) Medicare Part B annually spends billions of dollars to cover a limited number of outpatient prescription drugs.

Affordable Care Act (ACA)Direct Primary/Concierge Care Health Care Finance Health Care Redesign Health Insurance HRAs/HSAs Medicaid Medicare - General Part D/Prescription Drugs

Eileen Cook August 5, 2025August 5, 2025 ACA, CMS, Federal Budget Reconciliation Bill, Healthcare Costs, Healthcare Finance, Medicaid, medicare, Medicare Part D

Implementation Dates for 2025 Budget Reconciliation Law

(Source - The Kaiser Family Foundation published August 4, 2025) On July 4, President Trump signed the budget reconciliation bill,

FDA Part D/Prescription Drugs

Eileen Cook August 5, 2025 Drug Shortages, FDA, Medicare Part D

7 drugs in shortage

(By: Alexandra Murphy for Becker’s Hospital Review ) Here are seven new drugs and discontinuations, according to drug supply databases

Health Care Finance Part D/Prescription Drugs

Eileen Cook July 31, 2025July 31, 2025 Healthcare Costs, Healthcare Finance, Medicare Part D

Pharmaceutical costs expected to rise 3.35% in 2026: Vizient

(By: Alexandra Murphy for Becker’s Hospital Review ) Pharmaceutical prices are expected to rise by 3.35% in 2026, according to

Health Care Finance Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook July 30, 2025July 30, 2025 CMS, medicare, Medicare Advantage, Medicare Part D, Out-of-pocket costs, Premiums, Prior Authorization, Supplemental Benefits

Medicare Advantage in 2025: Premiums, Out-of-Pocket Limits, Supplemental Benefits, and Prior Authorization

(By Nancy Ochieng, Meredith Freed, Jeannie Fuglesten Biniek, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Jul

CMS Health Care Finance Part D/Prescription Drugs

Eileen Cook July 29, 2025July 29, 2025 CMS, Healthcare Costs, Healthcare Finance, Medicare Part D

2026 Medicare Part D Bid Information

The Centers for Medicare & Medicaid Services (CMS) has released preliminary technical Medicare Part D bid information for the 2026

CMS Health Care Finance Medicaid Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook July 29, 2025July 29, 2025 CMS, Healthcare Costs, Healthcare Finance, medicare, Medicare Advantage, Medicare Part D, MedPAC, Older Adults

Medicare Advantage in 2025: Enrollment Update and Key Trends

(By Nancy Ochieng, Meredith Freed, Jeannie Fuglesten Biniek, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Jul

Health Care Finance Health Care Redesign Legislative Update Part D/Prescription Drugs

Eileen Cook July 29, 2025July 29, 2025 340B drug discount program, Healthcare Costs, Healthcare Finance, Healthcare redesign, Medicare Part D

How health systems are preparing for a potential 340B overhaul

(By: Alexandra Murphy for Becker’s Hospital Review ) As federal scrutiny and legislative proposals continue around the 340B drug pricing

CMS Health Care Finance Medicare Advantage Part D/Prescription Drugs

Eileen Cook July 17, 2025July 17, 2025 CMS, medicare, Medicare Advantage, Medicare Part D, Older Adults

The Uncertain Future of Medicare’s Stand-Alone Prescription Drug Plan Market and Why It Matters

(By Juliette Cubanski and Tricia Neuman for KFF Health News Published: Jul 16, 2025) Ahead of Medicare’s annual mid-year announcement